WASHINGTON, D.C. — President Donald Trump has announced that the U.S. will impose tariffs on imported pharmaceuticals within the next week, as part of a push to bring drug manufacturing back to American soil.

“We want pharmaceuticals made in our country,” Trump said, underscoring the administration’s focus on reducing U.S. dependence on foreign supply chains, particularly from China, a major exporter of pharmaceutical ingredients and products to the U.S.

The planned tariffs are a key piece of Trump’s "America First" economic strategy, aimed at revitalizing domestic industries, boosting national security, and addressing vulnerabilities exposed during the COVID-19 pandemic, when global supply chains were severely strained.

While no specific tariff rates were mentioned, the policy is expected to target a broad range of drug imports, potentially affecting both generic and brand-name medications.

Critics warn the move could lead to short-term drug price increases, while supporters argue it’s a necessary step to secure U.S. health independence and protect critical industries from geopolitical risks.

Further details are expected in the official announcement later this week.